IF 2 Eye Drop contains Olopatadine 0.1% w/v, a selective histamine H1 receptor antagonist with mast cell stabilizing properties, indicated for the treatment of allergic conjunctivitis. Olopatadine effectively inhibits the release of histamine and other inflammatory mediators from mast cells, thereby reducing symptoms such as itching, redness, and swelling of the conjunctiva. This ophthalmic solution provides rapid relief from ocular itching associated with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. IF 2 Eye Drop is administered topically, typically one drop in the affected eye(s) twice daily or as directed by a healthcare professional. Its dual mechanism of action not only alleviates immediate hypersensitivity reactions but also prevents late-phase allergic responses. The formulation is generally well tolerated; however, patients may occasionally experience mild side effects such as transient burning or stinging upon instillation, dry eyes, or headache. Caution is advised in patients with hypersensitivity to olopatadine or any component of the formulation. IF 2 Eye Drop should be used with care in contact lens wearers, who should remove lenses prior to application and wait at least 10 minutes before reinsertion. It is essential to adhere to prescribed dosage and duration to achieve optimal therapeutic outcomes and minimize potential adverse effects.